[go: up one dir, main page]

MX2019003427A - Composiciones para cultivo celular y metodos para la produccion de polipeptidos. - Google Patents

Composiciones para cultivo celular y metodos para la produccion de polipeptidos.

Info

Publication number
MX2019003427A
MX2019003427A MX2019003427A MX2019003427A MX2019003427A MX 2019003427 A MX2019003427 A MX 2019003427A MX 2019003427 A MX2019003427 A MX 2019003427A MX 2019003427 A MX2019003427 A MX 2019003427A MX 2019003427 A MX2019003427 A MX 2019003427A
Authority
MX
Mexico
Prior art keywords
cell culture
methods
polypeptide production
culture compositions
compositions
Prior art date
Application number
MX2019003427A
Other languages
English (en)
Inventor
Martin Gawlitzek
Steven J Meier
Melissa S Mun
Natarajan Vijayasankaran
Sharat Varma
Boyan Zhang
Silvana R Arevalo
Veronica Carvalhal
Yi Yang
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49380652&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2019003427(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of MX2019003427A publication Critical patent/MX2019003427A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C12N5/005—Protein-free medium
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/38—Vitamins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se proporcionan medios de cultivo celular, tales como los medios de cultivo celular químicamente definidos, como son los métodos para utilizar los medios para el crecimiento celular (i.e. cultivo celular) y la producción de polipéptidos (e.g. anticuerpos). También se proporcionan las composiciones que comprenden los polipéptidos producidos por los métodos.
MX2019003427A 2012-04-24 2014-10-23 Composiciones para cultivo celular y metodos para la produccion de polipeptidos. MX2019003427A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261637778P 2012-04-24 2012-04-24
US201261637780P 2012-04-24 2012-04-24
US13/841,864 US20130281355A1 (en) 2012-04-24 2013-03-15 Cell culture compositions and methods for polypeptide production

Publications (1)

Publication Number Publication Date
MX2019003427A true MX2019003427A (es) 2020-11-12

Family

ID=49380652

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014012838A MX363493B (es) 2012-04-24 2013-04-24 Composiciones para cultivo celular y metodos para la produccion de polipetidos.
MX2019003427A MX2019003427A (es) 2012-04-24 2014-10-23 Composiciones para cultivo celular y metodos para la produccion de polipeptidos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014012838A MX363493B (es) 2012-04-24 2013-04-24 Composiciones para cultivo celular y metodos para la produccion de polipetidos.

Country Status (22)

Country Link
US (2) US20130281355A1 (es)
EP (2) EP2841561B1 (es)
JP (4) JP6367792B2 (es)
KR (2) KR102115052B1 (es)
CN (3) CN104428409A (es)
AR (1) AR090822A1 (es)
AU (2) AU2013251647B2 (es)
BR (1) BR112014026308A8 (es)
CA (1) CA2871006C (es)
ES (1) ES2716301T3 (es)
HK (1) HK1208496A1 (es)
HR (1) HRP20190484T1 (es)
IL (1) IL235235A0 (es)
MX (2) MX363493B (es)
MY (1) MY181513A (es)
NZ (1) NZ701791A (es)
PL (1) PL2841561T3 (es)
RU (2) RU2678142C2 (es)
SG (2) SG11201406903SA (es)
SI (1) SI2841561T1 (es)
WO (1) WO2013163294A1 (es)
ZA (2) ZA201408092B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0720293B2 (ja) 1986-11-20 1995-03-06 三洋電機株式会社 リモ−トコントロ−ル受信回路
US9150645B2 (en) 2012-04-20 2015-10-06 Abbvie, Inc. Cell culture methods to reduce acidic species
WO2013158273A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Methods to modulate c-terminal lysine variant distribution
AR095348A1 (es) * 2013-03-15 2015-10-07 Genentech Inc Medios de cultivo celular y métodos de producción de anticuerpos
KR20210037745A (ko) 2013-03-15 2021-04-06 제넨테크, 인크. 항산화제를 함유하는 세포 배양 조성물 및 폴리펩티드 생산 방법
EP3052640A2 (en) * 2013-10-04 2016-08-10 AbbVie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
AR103173A1 (es) 2014-12-22 2017-04-19 Novarits Ag Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17
GB201708655D0 (en) 2017-05-31 2017-07-12 Ucb Biopharma Sprl Cell culture methods
WO2018229802A1 (en) * 2017-06-16 2018-12-20 Ge Healthcare Bio-Sciences Ab Method for predicting outcome of and modelling of a process in a bioreactor
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN111500662A (zh) * 2018-06-25 2020-08-07 深圳市菲鹏生物制药股份有限公司 调节cho-k1表达系统所分泌抗体的酸性峰含量的方法
WO2021087232A1 (en) * 2019-10-31 2021-05-06 William Marsh Rice University Engineered cells for controlled production
US11186625B2 (en) 2019-12-06 2021-11-30 Regeneran Pharmaceuticals, Inc. Anti-VEGF protein compositions and methods for producing the same
WO2021153723A1 (ja) 2020-01-31 2021-08-05 中外製薬株式会社 着色を抑制したポリペプチドを含む組成物の製造方法
AU2021268026A1 (en) 2020-05-08 2023-01-19 Regeneron Pharmaceuticals, Inc. VEGF traps and mini-traps and methods for treating ocular disorders and cancer
GB202012991D0 (en) 2020-08-20 2020-10-07 Ucb Biopharma Sprl Cell culture processes
JP2023554489A (ja) * 2020-12-22 2023-12-27 ノバルティス アーゲー 細胞培養中の分泌された組換え発現タンパク質中のシステイン残基の酸化レベルを低減するための方法
WO2022204120A1 (en) * 2021-03-23 2022-09-29 Biogen Ma Inc. Reducing host cell impurities during recombinant protein production
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
WO2023031409A1 (en) 2021-09-02 2023-03-09 Boehringer Ingelheim International Gmbh Method of determining a future color value or corresponding property and arrangement therefor
KR102682066B1 (ko) * 2021-10-12 2024-07-05 프레스티지바이오로직스 주식회사 항체 집단의 제조 방법
CN115807135A (zh) * 2022-12-13 2023-03-17 上海臻格生物技术有限公司 一种生物反应器泡沫控制方法
GB202318647D0 (en) 2023-12-06 2024-01-17 Ucb Biopharma Sprl Cell culture processes

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30985E (en) 1978-01-01 1982-06-29 Serum-free cell culture media
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
JPS5863385A (ja) 1981-10-02 1983-04-15 ハナ・バイオロジツクス・インコ−ポレ−テツド 免疫系由来の細胞用培地
US4560655A (en) 1982-12-16 1985-12-24 Immunex Corporation Serum-free cell culture medium and process for making same
US4657866A (en) 1982-12-21 1987-04-14 Sudhir Kumar Serum-free, synthetic, completely chemically defined tissue culture media
US4713339A (en) 1983-01-19 1987-12-15 Genentech, Inc. Polycistronic expression vector construction
AU2353384A (en) 1983-01-19 1984-07-26 Genentech Inc. Amplification in eukaryotic host cells
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
GB8516415D0 (en) 1985-06-28 1985-07-31 Celltech Ltd Culture of animal cells
US4816401A (en) 1985-09-09 1989-03-28 University Of Rochester Serum free cell culture medium
US5091178A (en) 1986-02-21 1992-02-25 Oncogen Tumor therapy with biologically active anti-tumor antibodies
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
EP0435911B1 (en) 1988-09-23 1996-03-13 Cetus Oncology Corporation Cell culture medium for enhanced cell growth, culture longevity and product expression
US6048728A (en) 1988-09-23 2000-04-11 Chiron Corporation Cell culture medium for enhanced cell growth, culture longevity, and product expression
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
JPH03180176A (ja) * 1989-11-16 1991-08-06 W R Grace & Co 細胞培養のための基礎栄養培地
AU639047B2 (en) 1989-11-22 1993-07-15 Genentech Inc. Latency associated peptide and uses therefor
US5122469A (en) 1990-10-03 1992-06-16 Genentech, Inc. Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins
EP1136556B1 (en) 1991-11-25 2005-06-08 Enzon, Inc. Method of producing multivalent antigen-binding proteins
JPH07102147B2 (ja) * 1992-03-16 1995-11-08 株式会社ミドリ十字 ヒト血清アルブミンの着色抑制方法
US5856179A (en) 1994-03-10 1999-01-05 Genentech, Inc. Polypeptide production in animal cell culture
US5512477A (en) 1994-04-21 1996-04-30 Genzyme Corporation Serum-free medium supplement
US6267958B1 (en) 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
ATE222598T1 (de) * 1996-04-19 2002-09-15 Nestle Sa Menschliche immortalisierte colon- epithelialzellen
ATE399855T1 (de) * 1996-10-10 2008-07-15 Invitrogen Corp Tierzellkulturmedium mit pflanzlichen nährstoffen
US20020012991A1 (en) 1997-04-07 2002-01-31 Florence Chua Nee Ho Kit Fong Cell culture media for enhanced protein production
US6171586B1 (en) 1997-06-13 2001-01-09 Genentech, Inc. Antibody formulation
US6160099A (en) * 1998-11-24 2000-12-12 Jonak; Zdenka Ludmila Anti-human αv β3 and αv β5 antibodies
US20060286668A1 (en) 1999-04-30 2006-12-21 Invitrogen Corporation Animal-cell culture media comprising non-animal or plant-derived nutrients
US6900056B2 (en) * 2001-02-15 2005-05-31 Centocor, Inc. Chemically defined medium for cultured mammalian cells
EP1404813A4 (en) 2001-06-13 2004-11-24 Genentech Inc METHOD FOR CULTIVATING ANIMAL CELLS AND POLYPEPTIDE PRODUCTION IN ANIMAL CELLS
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
US7261893B2 (en) 2002-10-22 2007-08-28 Wyeth Neutralizing antibodies against GDF-8 and uses therefor
GB0304799D0 (en) * 2003-03-03 2003-04-09 Glaxosmithkline Biolog Sa Novel method
US20060104968A1 (en) 2003-03-05 2006-05-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
US7871607B2 (en) 2003-03-05 2011-01-18 Halozyme, Inc. Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
AU2004280065A1 (en) * 2003-10-09 2005-04-21 Kyowa Hakko Kirin Co., Ltd. Process for producing antibody composition by using RNA inhibiting the function of alpha1,6-fucosyltransferase
TWI384069B (zh) * 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
EP1812557A4 (en) * 2004-10-29 2009-11-04 Centocor Ortho Biotech Inc COMPOSITIONS OF CHEMICALLY DEFINED MEDIA
CN100569940C (zh) * 2006-08-16 2009-12-16 华东理工大学 人胚胎肾(hek)293细胞无血清培养基
CN103276033A (zh) * 2006-09-13 2013-09-04 雅培制药有限公司 细胞培养改良
AU2007331712A1 (en) 2006-12-11 2008-06-19 F. Hoffmann-La Roche Ag Abeta antibody parenteral formulation
JP4851543B2 (ja) * 2007-01-12 2012-01-11 日本板硝子株式会社 三次元細胞培養担体およびそれを用いた細胞培養方法
JP5349474B2 (ja) * 2007-07-20 2013-11-20 ドングク・ユニヴァーシティー・インダストリー−アカデミック・コーオペレーション・ファンデーション 間葉系幹細胞を利用して毛乳頭組職を製造する方法
MX2010002249A (es) * 2007-08-31 2010-03-17 Amgen Inc Formulacion de proteina de estado solido.
SI2310523T1 (sl) * 2008-04-17 2015-10-30 Wyeth Llc Postopki za boljšo proizvodnjo kostnih morfogenetskih proteinov
JP2012503487A (ja) * 2008-09-26 2012-02-09 シェーリング コーポレイション 高力価抗体の製造
JO3672B1 (ar) * 2008-12-15 2020-08-27 Regeneron Pharma أجسام مضادة بشرية عالية التفاعل الكيماوي بالنسبة لإنزيم سبتيليسين كنفرتيز بروبروتين / كيكسين نوع 9 (pcsk9).
US9540426B2 (en) * 2009-10-06 2017-01-10 Bristol-Myers Squibb Company Mammalian cell culture processes for protein production
RU2644651C2 (ru) 2010-04-26 2018-02-13 Новартис Аг Среда для культивирования клеток

Also Published As

Publication number Publication date
ES2716301T3 (es) 2019-06-11
JP2015515281A (ja) 2015-05-28
AU2019202259B2 (en) 2021-11-11
MX2014012838A (es) 2015-10-22
NZ701791A (en) 2017-03-31
HK1208496A1 (en) 2016-03-04
RU2678142C2 (ru) 2019-01-23
RU2014147018A (ru) 2016-06-10
EP3533864A1 (en) 2019-09-04
AR090822A1 (es) 2014-12-10
KR102115052B1 (ko) 2020-05-25
ZA201408092B (en) 2019-03-27
CN111440758A (zh) 2020-07-24
SI2841561T1 (sl) 2019-04-30
EP2841561B1 (en) 2019-01-16
JP2023156371A (ja) 2023-10-24
KR20150003351A (ko) 2015-01-08
BR112014026308A8 (pt) 2021-06-01
US20240093143A1 (en) 2024-03-21
US20130281355A1 (en) 2013-10-24
HRP20190484T1 (hr) 2019-05-17
ZA201707452B (en) 2021-03-31
CN111440758B (zh) 2024-12-13
SG11201406903SA (en) 2014-12-30
CA2871006A1 (en) 2013-10-31
EP2841561A1 (en) 2015-03-04
CN104428409A (zh) 2015-03-18
CA2871006C (en) 2021-05-25
KR20200057795A (ko) 2020-05-26
AU2013251647B2 (en) 2019-04-04
JP7323272B2 (ja) 2023-08-08
RU2018146497A (ru) 2019-02-04
CN119979437A (zh) 2025-05-13
JP2018183154A (ja) 2018-11-22
AU2013251647A1 (en) 2014-12-18
KR102339106B1 (ko) 2021-12-15
JP2021104023A (ja) 2021-07-26
MX363493B (es) 2019-03-26
JP6367792B2 (ja) 2018-08-01
PL2841561T3 (pl) 2019-05-31
BR112014026308A2 (pt) 2017-06-27
MY181513A (en) 2020-12-24
SG10201810830UA (en) 2018-12-28
WO2013163294A1 (en) 2013-10-31
AU2019202259A1 (en) 2019-04-18
IL235235A0 (en) 2014-12-31

Similar Documents

Publication Publication Date Title
MX2019003427A (es) Composiciones para cultivo celular y metodos para la produccion de polipeptidos.
SG10201809452RA (en) Cell culture compositions with antioxidants and methods for polypeptide production
MX2015011781A (es) Medio de cultivo celular y metodos de produccion de anticuerpos.
MY170720A (en) Antibody formulations
MX2021008142A (es) Metodos para cosechar cultivos de celulas de mamifero.
WO2013060867A3 (en) Production of heterodimeric proteins
MX356337B (es) Anticuerpos contra csf-1r humano y sus usos.
EP4477668A3 (en) Heterodimeric antibody fc-containing proteins and methods for production thereof
GB201203085D0 (en) Hydrogels
HK1218139A1 (zh) 去分化的重新編程細胞所衍生的細胞組合物
EA201590550A1 (ru) Композиции и способы получения гликопротеинов
EP4527921A3 (en) Renal cell populations and uses thereof
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
FI20115328A0 (fi) Uusia kutinaaseja, niiden tuottaminen ja käytöt
HK1220404A1 (zh) 用於细胞培养的细胞外基质组合物珠粒
MX2011012623A (es) Construcciones de casb7439.
MX2021001981A (es) Metodos para preparar un poloxamero para usar en medio de cultivo celular.
EA201791233A1 (ru) Материал стволовых клеток и способ его получения
MY169178A (en) Direct and indirect organogenesis of jatropha
WO2012054935A3 (en) Formation of hematopoietic progenitor cells from mesenchymal stem cells
WO2015117033A3 (en) Methods of increasing protein production in mammalian cells
EP3150700A4 (en) Culture medium and culturing method for anchorage-dependent cells, cell composition including stem cells and/or differentiated cells derived from stem cells, and production method for cell composition
HK40032375B (zh) 用於多肽生产的细胞培养组合物和方法
AU2016219622A1 (en) Heterodimeric antibody FC-containing proteins and methods for production thereof
MX346721B (es) Proceso mejorado para la obtención de galphiminas (a,b y e) con actividad ansiolitica a partir del cultivo in vitro de galphimia glauca.